HARMONY BIOSCIENCES HOLDINGS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $158.7M | $145.5M | $128.9M | $181.5M | $34.6M | $-36.9M | $-152.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | — | $267.0K | $514.0K | $419.0K | $416.0K | $394.0K | $395.0K |
| Amortization | $23.8M | $23.8M | $23.8M | $23.0M | $18.4M | $9.8M | $2.8M |
| Stock-Based Compensation | $44.9M | $42.6M | $31.7M | $26.2M | $15.7M | $4.7M | $9.9M |
| Net Cash from Operating Activities | $348.2M | $219.8M | $219.4M | $144.5M | $98.6M | $-3.0M | $-75.4M |
| Investing Activities | |||||||
| Capital Expenditures | $310.0K | $1.2M | $312.0K | $172.0K | $298.0K | $2.0K | $149.0K |
| Business Acquisitions | — | — | $37.0M | — | — | — | — |
| Net Cash from Investing Activities | $-39.6M | $-67.5M | $-46.4M | $-141.8M | $-100.3M | $-2.0M | $-127.1M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | $100.0M | — | — | $167.0K | — |
| Net Cash from Financing Activities | $-9.0M | $-11.0M | $-105.6M | $6.8M | $7.4M | $209.2M | $143.8M |
| Net Change in Cash | $299.5M | $141.3M | $67.4M | $9.5M | $5.7M | $204.2M | $-58.8M |
| Free Cash Flow | $347.9M | $218.7M | $219.1M | $144.3M | $98.3M | $-3.0M | $-75.6M |